ODOMZO caps 200 mg 30 pce

7680650650027 CH-65065 L01XJ02 07.16.4.

Reimbursement limitations:

ODOMZO2

ODOMZO est remboursé dans le traitement de patients adultes atteints d’un carcinome basocellulaire avancé (CBC), …

ODOMZO caps 200 mg 30 pce
ODOMZO caps 200 mg 30 pce
ODOMZO caps 200 mg 30 pce
1 / 3
google

Details

Product number
6506501
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
sonidegibum 200 mg ut sonidegibi diphosphas, crospovidonum, lactosum monohydricum 38.60 mg, poloxamerum 188, natrii laurilsulfas corresp. natrium 0.605 mg, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: gelatina, E 171, E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum q.s., pro capsula.

Articles (1)

Odomzo 200 mg, Hartkapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
28/02/2022
Professional SmPC
Français
28/02/2022
Professional SmPC
Italien
28/02/2022
Patient information leaflet
Allemand
25/03/2021
Patient information leaflet
Français
25/03/2021
Patient information leaflet
Italien
25/03/2021

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
38.6 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
0.605 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 5547.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2018

Authorization holder

Sun Pharma Switzerland Ltd

8832 Wollerau

Authorization information

Swissmedic authorization number
65065
Drug name
Odomzo, Hartkapseln
Galenic form
KAPS
ATC Code
L01XJ02
Authorization status
Z
Dispensation category
A
First authorization
30/06/2015
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Basalzellkarzinom

Packaging details

Description (FR)
ODOMZO caps 200 mg 30 pce
Description (DE)
ODOMZO Kaps 200 mg 30 Stk
Market launch
30/06/2015
Narcotic (BTM)
No

Other packaging sizes

ODOMZO caps 200 mg 10 pce
10 KAP
View